How many stocks are there of TELA Bio?
The current number of stocks of TELA Bio is 22.87 M undefined.
TELA Bio Stocks 2024
TELA Bio Stocks
22.87 M
TELA Bio Dividend yield
Ticker
TELA
ISIN
US8723811084
WKN
A2PUP9
In 2024, TELA Bio had 22.87 M outstanding stocks, a 0% change from the 22.87 M stocks in the previous year.
The TELA Bio Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2028e | 22.87 |
| 2027e | 22.87 |
| 2026e | 22.87 |
| 2025e | 22.87 |
| 2024e | 22.87 |
| 2023 | 22.87 |
| 2022 | 16.27 |
| 2021 | 14.47 |
| 2020 | 12.93 |
| 2019 | 11.41 |
| 2018 | 11.01 |
| 2017 | 11.01 |
TELA Bio Aktienanalyse
What does TELA Bio do?
TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating TELA Bio's Shares Outstanding
TELA Bio's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in TELA Bio’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding TELA Bio’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in TELA Bio’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about TELA Bio Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of TELA Bio are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of TELA Bio evolved in recent years?
The number of shares of TELA Bio has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. TELA Bio as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of TELA Bio?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does TELA Bio pay?
Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of TELA Bio?
The current dividend yield of TELA Bio is .
When does TELA Bio pay dividends?
TELA Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of TELA Bio?
TELA Bio paid dividends every year for the past 0 years.
What is the dividend of TELA Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is TELA Bio located?
TELA Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of TELA Bio from 5/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/26/2024.
When did TELA Bio pay the last dividend?
The last dividend was paid out on 5/26/2024.
What was the dividend of TELA Bio in the year 2023?
In the year 2023, TELA Bio distributed 0 USD as dividends.
In which currency does TELA Bio pay out the dividend?
The dividends of TELA Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von TELA Bio
Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
